Skip to main content

Want a detailed portfolio tracker?

Ocugen (OCGN) P/E (2014 - 2026)

Ocugen (OCGN) P/E from Dec 31, 2014 to Jun 3, 2026. The TTM Ocugen (OCGN) P/E is -5.70. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ocugen (OCGN)

YearP/EChange
2026-5.70-5.45%
2025-6.03+48.30%
2024-4.07+137.39%
2023-1.71-54.16%
2022-3.74-75.74%
2021-15.40+57.25%
2020-9.80-166.00%
201914.84-242.89%
2018-10.39-96.31%
2017-281.48+579.26%
2016-41.44-52.32%
2015-86.91-100.95%
20149.15KN/A

Comparison Ocugen (OCGN) P/E with competitors

Ocugen (OCGN) P/E is -5.70.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.10-101.79%
ENLVEnlivex Therapeutics Ltd0.15-102.63%
FGENFibroGen Inc0.24-104.21%
TRAWTraws Pharma Inc0.47-108.29%
FBIOFortress Biotech Inc0.71-112.38%
CHRSCoherus Biosciences Inc0.98-117.16%
ORMPOramed Pharmaceuticals Inc1.47-125.84%
AGENAgenus Inc2.05-135.93%
VIVSVivoSim Labs Inc2.54-144.48%
INVAInnoviva Inc3.19-155.93%
CRMDCorMedix Inc3.65-163.95%
ABEOAbeona Therapeutics Inc4.20-173.76%
VXRTVaxart Inc4.26-174.75%
CVACCureVac N.V.4.45-177.98%
SRPTSarepta Therapeutics Inc4.62-181.11%
GLPGGalapagos NV4.86-185.23%
RIGLRigel Pharmaceuticals4.92-186.29%
ZVRAZevra Therapeutics Inc4.97-187.25%
ABUSArbutus Biopharma Corp5.69-199.87%
CGENCompugen Ltd7.38-229.52%
AUPHAurinia Pharmaceuticals Inc9.25-262.27%
ACADAcadia Pharmaceuticals Inc9.59-268.18%
OMEROmeros Corporation9.88-273.36%
PLXProtalix BioTherapeutics Inc9.91-273.81%
SPROSpero Therapeutics Inc10.73-288.29%
ADMAAdma Biologics Inc11.33-298.74%
SVASinovac Biotech Ltd11.44-300.59%
TBPHTheravance Biopharma Inc11.78-306.57%
HRMYHarmony Biosciences Holdings Inc12.18-313.65%
TGTXTG Therapeutics Inc13.18-331.17%
INCYIncyte Corp13.38-334.73%
SABSSAB Biotherapeutics Inc14.06-346.58%
XOMAXOMA Corp14.95-362.15%
REGNRegeneron Pharmaceuticals Inc14.98-362.76%
PBYIPuma Biotechnology Inc15.05-363.99%
EXELExelixis Inc15.79-377.05%
NAGENiagen Bioscience Inc16.35-386.87%
CPRXCatalyst Pharmaceuticals Inc17.34-404.24%
MDXGMimedx Group Inc17.38-404.77%
ARGXArgen X SE23.07-504.69%
HALOHalozyme Therapeutics Inc23.20-506.95%
XOMAOXOMA Corp25.34-544.56%
VRTXVertex Pharmaceuticals Inc25.66-550.02%
XOMAPXOMA Corp25.67-550.27%
CTMXCytomX Therapeutics Inc25.70-550.76%
ASNDAscendis Pharma A/S26.35-562.27%
RPRXRoyalty Pharma plc - Class A27.50-582.29%
SLNOSoleno Therapeutics Inc29.02-608.95%
LGNDLigand Pharmaceuticals Inc - Class B30.19-629.49%
BMRNBiomarin Pharmaceutical Inc37.51-757.90%
APLSApellis Pharmaceuticals Inc39.02-784.45%
KRYSKrystal Biotech Inc39.70-796.32%
GMABGenmab40.20-805.19%
ONCBeiGene Ltd67.03-1275.69%
TECHBio-Techne Corp68.59-1303.20%
VCELVericel Corp80.63-1514.28%
PHARPharming Group N.V.87.74-1639.01%
ALNYAlnylam Pharmaceuticals Inc124.93-2291.41%
TLXTelix Pharmaceuticals Ltd139.89-2553.77%
CORTCorcept Therapeutics Inc158.39-2878.24%